Aspen Japan Starting on Right Foot on AG Biz: GSK Japan President

GSK Japan President Philippe Fauchet As the Japan arm of GlaxoSmithKline gauges the viability of the authorized generic (AG) model through Aspen Japan, GSK Japan President Philippe Fauchet believes the partner is “starting on the right foot” on its AG...read more